Menu
GeneBe

rs10866916

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_201384.3(PLEC):c.1815+13A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,610,440 control chromosomes in the GnomAD database, including 121,517 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 11683 hom., cov: 32)
Exomes 𝑓: 0.38 ( 109834 hom. )

Consequence

PLEC
NM_201384.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.30
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 8-143932622-T-C is Benign according to our data. Variant chr8-143932622-T-C is described in ClinVar as [Benign]. Clinvar id is 93035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-143932622-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLECNM_201378.4 linkuse as main transcriptc.1773+13A>G intron_variant ENST00000356346.7
PLECNM_201384.3 linkuse as main transcriptc.1815+13A>G intron_variant ENST00000345136.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLECENST00000345136.8 linkuse as main transcriptc.1815+13A>G intron_variant 1 NM_201384.3 Q15149-4
PLECENST00000356346.7 linkuse as main transcriptc.1773+13A>G intron_variant 1 NM_201378.4 Q15149-9

Frequencies

GnomAD3 genomes
AF:
0.387
AC:
58706
AN:
151758
Hom.:
11666
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.427
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.333
Gnomad ASJ
AF:
0.452
Gnomad EAS
AF:
0.148
Gnomad SAS
AF:
0.346
Gnomad FIN
AF:
0.388
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.392
Gnomad OTH
AF:
0.398
GnomAD3 exomes
AF:
0.352
AC:
83393
AN:
237080
Hom.:
15485
AF XY:
0.357
AC XY:
46536
AN XY:
130252
show subpopulations
Gnomad AFR exome
AF:
0.418
Gnomad AMR exome
AF:
0.248
Gnomad ASJ exome
AF:
0.461
Gnomad EAS exome
AF:
0.143
Gnomad SAS exome
AF:
0.344
Gnomad FIN exome
AF:
0.399
Gnomad NFE exome
AF:
0.393
Gnomad OTH exome
AF:
0.382
GnomAD4 exome
AF:
0.385
AC:
560910
AN:
1458566
Hom.:
109834
Cov.:
62
AF XY:
0.384
AC XY:
278349
AN XY:
725588
show subpopulations
Gnomad4 AFR exome
AF:
0.426
Gnomad4 AMR exome
AF:
0.261
Gnomad4 ASJ exome
AF:
0.459
Gnomad4 EAS exome
AF:
0.167
Gnomad4 SAS exome
AF:
0.347
Gnomad4 FIN exome
AF:
0.391
Gnomad4 NFE exome
AF:
0.397
Gnomad4 OTH exome
AF:
0.386
GnomAD4 genome
AF:
0.387
AC:
58753
AN:
151874
Hom.:
11683
Cov.:
32
AF XY:
0.384
AC XY:
28510
AN XY:
74226
show subpopulations
Gnomad4 AFR
AF:
0.427
Gnomad4 AMR
AF:
0.332
Gnomad4 ASJ
AF:
0.452
Gnomad4 EAS
AF:
0.148
Gnomad4 SAS
AF:
0.345
Gnomad4 FIN
AF:
0.388
Gnomad4 NFE
AF:
0.392
Gnomad4 OTH
AF:
0.394
Alfa
AF:
0.393
Hom.:
2142
Bravo
AF:
0.381
Asia WGS
AF:
0.243
AC:
849
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015c.2226+13A>G in intron 15 of PLEC: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence. It has been identified in 40.0% (1561/3904) of African American chromoso mes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs .washington.edu/EVS; dbSNP rs10866916). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 04, 2013- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 05, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Epidermolysis bullosa simplex with nail dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Epidermolysis bullosa simplex 5C, with pyloric atresia Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex 5B, with muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Autosomal recessive limb-girdle muscular dystrophy type 2Q Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -
Epidermolysis bullosa simplex, Ogna type Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabOct 25, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
Cadd
Benign
0.79
Dann
Benign
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10866916; hg19: chr8-145006790; COSMIC: COSV104402298; COSMIC: COSV104402298; API